Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Facts and ideas from anywhere.

Literature DB >> 16200106

Facts and ideas from anywhere.

William Clifford Roberts.

Abstract

Year: 2004 PMID： 16200106 PMCID： PMC1200658 DOI： 10.1080/08998280.2004.11927975

Source DB: PubMed Journal: Proc (Bayl Univ Med Cent) ISSN： 0899-8280

Keyword Cloud
References

× No keyword cloud information.

15 in total

1. Comparison of effects of simvastatin versus atorvastatin on high-density lipoprotein cholesterol and apolipoprotein A-I levels.

Authors: J J Kastelein; J L Isaacsohn; L Ose; D B Hunninghake; J Frohlich; M H Davidson; R Habib; C A Dujovne; J R Crouse; M Liu; M R Melino; L O'Grady; M Mercuri; Y B Mitchel
Journal: Am J Cardiol Date: 2000-07-15 Impact factor: 2.778

2. Cerivastatin and reports of fatal rhabdomyolysis.

Authors: Judy A Staffa; Jennie Chang; Lanh Green
Journal: N Engl J Med Date: 2002-02-14 Impact factor: 91.245

3. The GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) study.

Authors: Dimitri P Mikhailidis; Anthony S Wierzbicki
Journal: Curr Med Res Opin Date: 2002 Impact factor: 2.580

4. The statin wars: why AstraZeneca must retreat.

Authors:
Journal: Lancet Date: 2003-10-25 Impact factor: 79.321

5. Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial--Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial.

Authors: Peter S Sever; Björn Dahlöf; Neil R Poulter; Hans Wedel; Gareth Beevers; Mark Caulfield; Rory Collins; Sverre E Kjeldsen; Arni Kristinsson; Gordon T McInnes; Jesper Mehlsen; Markku Nieminen; Eoin O'Brien; Jan Ostergren
Journal: Lancet Date: 2003-04-05 Impact factor: 79.321

6. Efficacy and safety of ezetimibe added to ongoing statin therapy for treatment of patients with primary hypercholesterolemia.

Authors: Claude Gagné; Harold E Bays; Stuart R Weiss; Pedro Mata; Katherine Quinto; Michael Melino; Meehyung Cho; Thomas A Musliner; Barry Gumbiner
Journal: Am J Cardiol Date: 2002-11-15 Impact factor: 2.778

7. Efficacy and safety of a potent new selective cholesterol absorption inhibitor, ezetimibe, in patients with primary hypercholesterolemia.

Authors: Carlos A Dujovne; Mark P Ettinger; J Frederick McNeer; Leslie J Lipka; Alexandre P LeBeaut; Ramachandran Suresh; Bo Yang; Enrico P Veltri
Journal: Am J Cardiol Date: 2002-11-15 Impact factor: 2.778